We hypothesized that ER PR breast tumors are more likely than ER PR breast tumors to have an aggressive phenotype, to express HER 1 and overexpress HER 2, and are less likely to benefit from tamoxifen adjuvant therapy

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Klaiss Luna MC, Manrique Moreno M